# EDGAR Filing Document

**Accession Number:** 0001997296
**File Stem:** 0001062993-25-017143
**Filing Date:** 2025-12
**Character Count:** 2199
**Document Hash:** 67fdb3b7916ae77bc389b1ed7264f670
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-25-017143.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001062993-25-017143

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medicus Pharma Ltd.
- **CENTRAL INDEX KEY:** 0001997296
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 981778211
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 300 CONSHOHOCKEN STATE RD.
- **STREET 2:** SUITE 200
- **CITY:** W. CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428
- **BUSINESS PHONE:** 610-540-7515

**MAIL ADDRESS:**
- **STREET 1:** 300 CONSHOHOCKEN STATE RD.
- **STREET 2:** SUITE 200
- **CITY:** W. CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428

------

**Medicus Pharma Ltd.**<br>300 Conshohocken State Road, Suite 200<br>Conshohocken, PA 19428

December 2, 2025

<u>VIA EDGAR</u><br>Division of Corporation Finance<br>Office of Life Sciences<br>Securities and Exchange Commission<br>100 F Street, N.E.<br>Washington, D.C. 20549

**Re: Medicus Pharma Ltd.**<br>**Registration Statement on Form S-1 (No. 333-291651)** <br>**Filed November 19, 2025**<br>Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, we hereby request that the effective date of the Registration Statement on Form S-1, File No. 333-291651, as amended (the "<u>Registration Statement</u>"), relating to the registration of up to 2,680,000 common shares of Medicus Pharma Ltd. (the "Company") be accelerated to December 4, 2025 at 5:00 PM ET or as soon thereafter as may be practicable.

Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

\*\*\*\*\*

------

Very truly yours,<br>By: <u>/s/ Raza Bokhari</u> <br>Name: Dr. Raza Bokhari<br>Title: Executive Chairman and Chief Executive Officer

------